Isolation methods commonly used to study the liposomal protein corona suffer from contamination issues

Nanoscale characterization of the biomolecular corona by cryo-electron microscopy, cryo-electron tomography, and image simulation

(2021) Sara Sheibani et al.   Nature Communications

Deciphering Protein Corona by scFv-Based Affinity Chromatography

(2021) Yuxiu Chu et al.   NANO LETTERS

Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease

(2021) Marilena Hadjidemetriou et al.   ACS Nano

Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study

(2021) Wouter J.M. Lokerse et al.   JOURNAL OF CONTROLLED RELEASE

Hard and Soft Protein Corona of Nanomaterials: Analysis and Relevance

(2021) Rafaela García-Álvarez et al.   Nanomaterials

Tuning liposome composition to modulate the corona forming in human serum and uptake by cells

(2020) Keni Yang et al.   Acta Biomaterialia

Pay attention to the biological nanoparticles when studying the protein corona on nanomedicines

(2020) Jens B Simonsen et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers

(2020) Germán Berrecoso et al.   Drug Delivery and Translational Research

Unbiased Identification of the Liposome Protein Corona using Photoaffinity-based Chemoproteomics

(2020) Roy Pattipeiluhu et al.   ACS Central Science

In Situ Analysis of Weakly Bound Proteins Reveals Molecular Basis of Soft Corona Formation

(2020) Daniel Sanchez-Guzman et al.   ACS Nano

Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association

(2020) Hossein Mohammad-Beigi et al.   Nature Communications

Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona

(2019) Claudia Weber et al.   BIOMACROMOLECULES

The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry

(2019) Manoj Khadka et al.   Biomolecules

The hard protein corona of stealth liposomes is sparse

(2019) Kasper Kristensen et al.   JOURNAL OF CONTROLLED RELEASE

Best practice in reporting corona studies: Minimum information about Nanomaterial Biocorona Experiments (MINBE)

(2019) Andrew J. Chetwynd et al.   Nano Today

Interplay of protein corona and immune cells controls blood residency of liposomes

(2019) Francesca Giulimondi et al.   Nature Communications

Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery

(2018) Giulio Caracciolo et al.   ACS Applied Materials & Interfaces

Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes

(2018) Zahraa S. Al-Ahmady et al.   JOURNAL OF CONTROLLED RELEASE

Shedding light on the cell biology of extracellular vesicles

(2018) Guillaume van Niel et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles

(2018) Vivian P. Vu et al.   Nature Nanotechnology

Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes

(2017) Dora Mehn et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations

(2017) Edward Cedrone et al.   MOLECULES

Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells

(2017) M. Papi et al.   Nanoscale

Liposomal Formulations in Clinical Use: An Updated Review

(2017) Upendra Bulbake et al.   Pharmaceutics

The nanoparticle protein corona formed in human blood or human blood fractions

(2017) Martin Lundqvist et al.   PLoS One

Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties

(2016) Arafeh Bigdeli et al.   ACS Nano

Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake

(2016) S. Schöttler et al.   Nanoscale

Binding of human serum albumin to PEGylated liposomes: insights into binding numbers and dynamics by fluorescence correlation spectroscopy

(2016) Kasper Kristensen et al.   Nanoscale

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles

(2016) Marilena Hadjidemetriou et al.   Nanoscale

The Perseus computational platform for comprehensive analysis of (prote)omics data

(2016) Stefka Tyanova et al.   NATURE METHODS

In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles

(2015) Marilena Hadjidemetriou et al.   ACS Nano

The nanoparticle biomolecule corona: lessons learned – challenge accepted?

(2015) D. Docter et al.   CHEMICAL SOCIETY REVIEWS

Liposome–protein corona in a physiological environment: Challenges and opportunities for targeted delivery of nanomedicines

(2015) Giulio Caracciolo   Nanomedicine-Nanotechnology Biology and Medicine

Advances and Challenges of Liposome Assisted Drug Delivery

(2015) Lisa Sercombe et al.   Frontiers in Pharmacology

Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells

(2014) Joana Marques et al.   Nanomedicine-Nanotechnology Biology and Medicine

The liposome–protein corona in mice and humans and its implications for in vivo delivery

(2014) G. Caracciolo et al.   Journal of Materials Chemistry B

Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery

(2013) Ana Lilia Barrán-Berdón et al.   LANGMUIR

Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

(2013) Stefan Tenzer et al.   Nature Nanotechnology

Reversible versus Irreversible Binding of Transferrin to Polystyrene Nanoparticles: Soft and Hard Corona

(2012) Silvia Milani et al.   ACS Nano

Liposomal drug delivery systems: From concept to clinical applications

(2012) Theresa M. Allen et al.   ADVANCED DRUG DELIVERY REVIEWS

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Do plasma proteins distinguish between liposomes of varying charge density?

(2012) Anna Laura Capriotti et al.   Journal of Proteomics

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

(2010) Akin Akinc et al.   MOLECULAR THERAPY

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY